Start your journey with G&L
Discover what G&L can do for you today.
Medium-sized Biotechnology company.
Our client required clinical, non-clinical, and CMC gap analyses for a US IND.
As part of this project, we identified strategies to maximize the use of data from ex-US studies to support the US IND and also highlighted potential GMP issues with suppliers.
As a result of our analyses, the client is currently investigating formulations with compendial excipients that have similar functionalities to avoid additional non-clinical work.
They are also exploring strategies to develop a phased IND-opening protocol that includes increased safety monitoring to support a 6-week IND-opening protocol.
Discover what G&L can do for you today.